Applied Therapeutics (APLT) Competitors $0.55 -0.01 (-1.86%) Closing price 04:00 PM EasternExtended Trading$0.55 0.00 (-0.78%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock APLT vs. NGNE, ATAI, LFCR, ACB, KRRO, PRME, NVCT, ACIU, BTMD, and ELDNShould you be buying Applied Therapeutics stock or one of its competitors? The main competitors of Applied Therapeutics include Neurogene (NGNE), Atai Life Sciences (ATAI), Lifecore Biomedical (LFCR), Aurora Cannabis (ACB), Korro Bio (KRRO), Prime Medicine (PRME), Nuvectis Pharma (NVCT), AC Immune (ACIU), biote (BTMD), and Eledon Pharmaceuticals (ELDN). These companies are all part of the "pharmaceutical products" industry. Applied Therapeutics vs. Neurogene Atai Life Sciences Lifecore Biomedical Aurora Cannabis Korro Bio Prime Medicine Nuvectis Pharma AC Immune biote Eledon Pharmaceuticals Applied Therapeutics (NASDAQ:APLT) and Neurogene (NASDAQ:NGNE) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations. Do insiders & institutionals believe in APLT or NGNE? 98.3% of Applied Therapeutics shares are held by institutional investors. Comparatively, 52.4% of Neurogene shares are held by institutional investors. 8.6% of Applied Therapeutics shares are held by insiders. Comparatively, 9.9% of Neurogene shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer APLT or NGNE? Applied Therapeutics currently has a consensus price target of $6.10, indicating a potential upside of 1,008.28%. Neurogene has a consensus price target of $59.80, indicating a potential upside of 313.27%. Given Applied Therapeutics' higher probable upside, research analysts plainly believe Applied Therapeutics is more favorable than Neurogene.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Applied Therapeutics 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50Neurogene 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Does the media prefer APLT or NGNE? In the previous week, Neurogene had 3 more articles in the media than Applied Therapeutics. MarketBeat recorded 5 mentions for Neurogene and 2 mentions for Applied Therapeutics. Neurogene's average media sentiment score of 0.53 beat Applied Therapeutics' score of 0.00 indicating that Neurogene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Applied Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Neurogene 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is APLT or NGNE more profitable? Neurogene's return on equity of -32.81% beat Applied Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Applied TherapeuticsN/A -260.75% -76.04% Neurogene N/A -32.81%-27.96% Which has stronger valuation and earnings, APLT or NGNE? Neurogene has higher revenue and earnings than Applied Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApplied Therapeutics-$212K-302.09-$119.76M-$1.61-0.34Neurogene$925K232.38-$36.32MN/AN/A Does the MarketBeat Community believe in APLT or NGNE? Applied Therapeutics received 52 more outperform votes than Neurogene when rated by MarketBeat users. However, 100.00% of users gave Neurogene an outperform vote while only 57.55% of users gave Applied Therapeutics an outperform vote. CompanyUnderperformOutperformApplied TherapeuticsOutperform Votes8057.55% Underperform Votes5942.45% NeurogeneOutperform Votes28100.00% Underperform VotesNo Votes Which has more volatility and risk, APLT or NGNE? Applied Therapeutics has a beta of 1.88, meaning that its share price is 88% more volatile than the S&P 500. Comparatively, Neurogene has a beta of 1.01, meaning that its share price is 1% more volatile than the S&P 500. SummaryNeurogene beats Applied Therapeutics on 12 of the 16 factors compared between the two stocks. Remove Ads Get Applied Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLT vs. The Competition Export to ExcelMetricApplied TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$64.04M$6.98B$5.67B$8.31BDividend YieldN/A2.72%4.55%4.02%P/E Ratio-0.347.2024.5919.28Price / Sales-302.09230.15395.6393.47Price / CashN/A65.6738.1634.64Price / Book-2.756.617.054.46Net Income-$119.76M$142.13M$3.20B$247.07M7 Day Performance5.70%2.66%1.42%3.04%1 Month Performance3.07%2.49%5.77%-2.86%1 Year Performance-91.85%-4.51%14.93%4.61% Applied Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLTApplied Therapeutics3.8246 of 5 stars$0.55-1.9%$6.10+1,010.5%-91.7%$63.91M$-212,000.00-0.3430Upcoming EarningsNGNENeurogene2.2937 of 5 stars$16.85+0.9%$60.83+260.9%-72.0%$250.37M$925,000.000.0090Earnings ReportAnalyst ForecastNews CoverageATAIAtai Life Sciences2.6645 of 5 stars$1.46-1.7%$9.00+518.6%-3.7%$244.15M$331,000.00-1.8080Upcoming EarningsAnalyst RevisionGap UpLFCRLifecore Biomedical1.7816 of 5 stars$6.55+1.2%$8.00+22.2%+27.2%$242.33M$130.86M-11.69690ACBAurora Cannabis0.8441 of 5 stars$4.39-0.6%N/A-6.0%$240.55M$320.81M87.721,073KRROKorro Bio1.504 of 5 stars$24.86+0.9%$144.00+479.2%-63.0%$232.89MN/A0.0070Earnings ReportAnalyst RevisionPRMEPrime Medicine2.7224 of 5 stars$1.75-2.3%$13.13+650.9%-70.7%$229.27M$2.98M-0.85234NVCTNuvectis Pharma3.2925 of 5 stars$9.50+7.3%$15.00+57.9%+8.8%$222.22MN/A-8.198Gap UpACIUAC Immune3.3727 of 5 stars$2.22-3.3%$12.00+441.8%-30.9%$219.15M$40.97M-4.82140News CoveragePositive NewsBTMDbiote3.5602 of 5 stars$4.00+6.5%$8.00+99.9%-38.1%$217.51M$197.19M15.40194Gap DownHigh Trading VolumeELDNEledon Pharmaceuticals1.8337 of 5 stars$3.63-0.6%$12.50+244.6%+79.6%$216.67MN/A-1.8010Earnings ReportUpcoming EarningsAnalyst RevisionNews CoveragePositive News Remove Ads Related Companies and Tools Related Companies Neurogene Alternatives Atai Life Sciences Alternatives Lifecore Biomedical Alternatives Aurora Cannabis Alternatives Korro Bio Alternatives Prime Medicine Alternatives Nuvectis Pharma Alternatives AC Immune Alternatives biote Alternatives Eledon Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLT) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy APLT Stock Free APLT Stock Alerts